Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Fish and Richardson
Johnson and Johnson
Argus Health

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,978,698

« Back to Dashboard

Which drugs does patent 5,978,698 protect, and when does it expire?

Patent 5,978,698 protects AGGRASTAT and is included in two NDAs.

This patent has three patent family members in one country.

Summary for Patent: 5,978,698

Title: Angioplasty procedure using nonionic contrast media
Abstract:A method for treating patients in need of percutaneous transluminal coronary angioplasty which comprises administering nonionic contract media to the patient and treating the patient with a fibrinogen receptor antagonist.
Inventor(s): Sax; Frederic L. (Villanova, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:08/943,872
Patent Claim Types:
see list of patent claims

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
MedicureAGGRASTATtirofiban hydrochlorideINJECTABLE;INJECTION020913-002May 17, 2002RXYesNo► Subscribe► Subscribe► Subscribe
MedicureAGGRASTATtirofiban hydrochlorideINJECTABLE;INJECTION020912-001May 14, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
MedicureAGGRASTATtirofiban hydrochlorideINJECTABLE;INJECTION020913-003Apr 20, 2000RXYesYes► Subscribe► Subscribe► Subscribe
MedicureAGGRASTATtirofiban hydrochlorideINJECTABLE;INJECTION020913-001May 14, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
MedicureAGGRASTATtirofiban hydrochlorideSOLUTION;INJECTION020912-002Aug 31, 2016RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 5,978,698

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
United Kingdom2318053► Subscribe
United Kingdom9626396► Subscribe
United Kingdom9720996► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Queensland Health
US Army
Cantor Fitzgerald
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: